Analysts See $2.08 EPS for Express Scripts Holding Company (ESRX)

January 20, 2018 - By Louis Casey

 Analysts See $2.08 EPS for Express Scripts Holding Company (ESRX)
Investors sentiment increased to 0.62 in 2017 Q3. Its up 0.06, from 0.56 in 2017Q2. It improved, as 66 investors sold Express Scripts Holding Company shares while 414 reduced holdings. 72 funds opened positions while 224 raised stakes. 486.80 million shares or 2.59% less from 499.72 million shares in 2017Q2 were reported.
Wellington Shields Capital Mngmt Lc reported 27,218 shares or 0.23% of all its holdings. Grp One Trading Ltd Partnership holds 0.01% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX) for 8,841 shares. Creative Planning holds 0.02% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX) for 66,082 shares. Caisse De Depot Et Placement Du Quebec, a Quebec – Canada-based fund reported 485,057 shares. Clough Prns L P owns 1.58% invested in Express Scripts Holding Company (NASDAQ:ESRX) for 371,700 shares. Guggenheim Cap Lc holds 1.17M shares or 0.17% of its portfolio. Janney Montgomery Scott Llc holds 0.1% or 145,071 shares. The Ontario – Canada-based Sun Life Financial has invested 0.03% in Express Scripts Holding Company (NASDAQ:ESRX). Northcoast Asset Ltd Liability Co has invested 2.93% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX). Mitsubishi Ufj Securities Limited holds 0.13% or 440 shares in its portfolio. Rampart Lc reported 0.17% stake. Dimensional Fund Ltd Partnership reported 6.55 million shares. Citigroup Inc has invested 0.03% in Express Scripts Holding Company (NASDAQ:ESRX). Douglass Winthrop Advsrs Ltd Liability Company reported 0.02% in Express Scripts Holding Company (NASDAQ:ESRX). Brave Asset stated it has 0.2% in Express Scripts Holding Company (NASDAQ:ESRX).

Analysts expect Express Scripts Holding Company (NASDAQ:ESRX) to report $2.08 EPS on February, 13.They anticipate $0.20 EPS change or 10.64 % from last quarter’s $1.88 EPS. ESRX’s profit would be $1.18 billion giving it 9.64 P/E if the $2.08 EPS is correct. After having $1.90 EPS previously, Express Scripts Holding Company’s analysts see 9.47 % EPS growth. The stock increased 0.28% or $0.22 during the last trading session, reaching $80.22. About 3.65M shares traded. Express Scripts Holding Company (NASDAQ:ESRX) has declined 16.92% since January 20, 2017 and is downtrending. It has underperformed by 33.62% the S&P500.

Express Scripts Holding Company (NASDAQ:ESRX) Ratings Coverage

Among 24 analysts covering Express Scripts (NASDAQ:ESRX), 10 have Buy rating, 3 Sell and 11 Hold. Therefore 42% are positive. Express Scripts has $96 highest and $57 lowest target. $79.53’s average target is -0.86% below currents $80.22 stock price. Express Scripts had 52 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Express Scripts Holding Company (NASDAQ:ESRX) has “Underweight” rating given on Monday, June 20 by Morgan Stanley. On Tuesday, January 9 the stock rating was maintained by Robert W. Baird with “Buy”. The rating was maintained by Oppenheimer on Wednesday, July 26 with “Hold”. The firm has “Buy” rating by Mizuho given on Wednesday, January 13. The firm has “Buy” rating by Jefferies given on Friday, May 26. The company was maintained on Wednesday, October 25 by RBC Capital Markets. The firm has “Underperform” rating by Bernstein given on Thursday, June 16. The firm has “Buy” rating given on Tuesday, July 18 by Maxim Group. Leerink Swann maintained Express Scripts Holding Company (NASDAQ:ESRX) on Wednesday, March 23 with “Market Perform” rating. The stock of Express Scripts Holding Company (NASDAQ:ESRX) earned “Equal-Weight” rating by Morgan Stanley on Thursday, January 21.

Express Scripts Holding Company operates as a pharmacy benefit management firm in the United States, Canada, and Europe. The company has market cap of $45.43 billion. It operates in two divisions, PBM and Other Business Operations. It has a 13.17 P/E ratio. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services.

More recent Express Scripts Holding Company (NASDAQ:ESRX) news were published by: Fool.com which released: “Why Express Scripts Holding Company Broke Out in December” on January 07, 2018. Also Globenewswire.com published the news titled: “Express Scripts Holding Company Announces Fourth Quarter and Full Year 2017 …” on January 09, 2018. Reuters.com‘s news article titled: “Express Scripts unit beats charity donation whistleblower lawsuit” with publication date: January 19, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.